Lipopolysaccharide binding protein derivatives

作者: Patrick W. Trown , Héle{overscore }e Gazzano-Santoro , Georgia Theofan

DOI:

关键词:

摘要: Disclosed are novel biologically active lipopolysaccharide binding protein (LBP) derivatives including LBP derivative hybrid proteins which characterized by the ability to bind and neutralize LPS lack CD14-mediated immunostimulatory properties of holo-LBP.

参考文章(57)
R. J. Ulevitch, D. C. Morrison, The effects of bacterial endotoxins on host mediation systems. A review. American Journal of Pathology. ,vol. 93, pp. 526- 618 ,(1978)
R.G. Little, D.N. Kelner, E. Lim, D.J. Burke, P.J. Conlon, Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23) Journal of Biological Chemistry. ,vol. 269, pp. 1865- 1872 ,(1994) , 10.1016/S0021-9258(17)42107-7
K Mészáros, J B Parent, I Chan, C Birr, H Kasler, S F Carroll, G Theofan, A H Horwitz, P S Liu, R E Williams, An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity Journal of Immunology. ,vol. 152, pp. 3623- 3629 ,(1994)
Richard Ulevitch, Peter Tobias, John C. Mathison, Samuel D. Wright, Methods and compositions for ameliorating the symptoms of sepsis ,(1990)
J. Han, J.C. Mathison, R.J. Ulevitch, P.S. Tobias, Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. Journal of Biological Chemistry. ,vol. 269, pp. 8172- 8175 ,(1994) , 10.1016/S0021-9258(17)37176-4